Scholar Rock Holding (SRRK) Selling, General & Administrative (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 1.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -37.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.17 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 493.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -1.52 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 647.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 50.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.20 Mn |
| Dec 31, 2025 | 45.02 Mn |
| Sep 30, 2025 | 53.06 Mn |
| Jun 30, 2025 | 49.71 Mn |
| Mar 31, 2025 | 28.41 Mn |
| Dec 31, 2024 | 18.99 Mn |
| Sep 30, 2024 | 16.06 Mn |
| Jun 30, 2024 | 17.13 Mn |
| Mar 31, 2024 | 15.33 Mn |
| Dec 31, 2023 | 13.07 Mn |
| Sep 30, 2023 | 13.34 Mn |
| Jun 30, 2023 | 12.22 Mn |
| Mar 31, 2023 | 10.77 Mn |
| Dec 31, 2022 | 10.82 Mn |
| Sep 30, 2022 | 10.47 Mn |
| Jun 30, 2022 | 11.07 Mn |
| Mar 31, 2022 | 10.76 Mn |
| Dec 31, 2021 | 10.36 Mn |
| Sep 30, 2021 | 11.28 Mn |
| Jun 30, 2021 | 9.27 Mn |
| Mar 31, 2021 | 9.37 Mn |
| Dec 31, 2020 | 7.76 Mn |
| Sep 30, 2020 | 8.27 Mn |
| Jun 30, 2020 | 6.37 Mn |
| Mar 31, 2020 | 5.82 Mn |
| Dec 31, 2019 | 5.86 Mn |
| Sep 30, 2019 | 6.18 Mn |
| Jun 30, 2019 | 4.71 Mn |
| Mar 31, 2019 | 4.07 Mn |
| Dec 31, 2018 | 5.44 Mn |
| Sep 30, 2018 | 3.17 Mn |
| Jun 30, 2018 | 3.46 Mn |
| Mar 31, 2018 | 2.32 Mn |
| Dec 31, 2017 | 1.57 Mn |
| Sep 30, 2017 | 1.16 Mn |
| Jun 30, 2017 | 1.18 Mn |